WhichRecall
Class I — UrgentReported 2025-12-03

Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 63323-739-12 (unit of sale).

Recalled by Fresenius Kabi USA, LLC

Reason for Recall

Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.

Advertisement
Recall Number
D-0182-2026
Classification
Class I
Status
Ongoing
Category
drug
Initiated
2025-11-06
Reported
2025-12-03
Distribution
Nationwide within the United States as well as AK, HI, and PR.
Code Info
Lot #: 6133156, 6133194, Exp Date: 08/2026; 6133388, Exp Date: 10/2026.
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement